TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
Antalya Training and Research Hospital
Antalya Training and Research Hospital
Henan Cancer Hospital
Sheba Medical Center
Kayseri City Hospital
Azienda USL Reggio Emilia - IRCCS
Başakşehir Çam & Sakura City Hospital
Henan Cancer Hospital
ASL Lecce
Henan Cancer Hospital
Instituto Nacional de Cancerologia, Columbia
National Cancer Center, Japan
Sheba Medical Center
Henan Cancer Hospital
Turku University Hospital
Biobizkaia Health Research Institute
National Cancer Center, Korea
Henan Cancer Hospital
Sheba Medical Center
Ankara Ataturk Sanatorium Training and Research Hospital
Manchester University NHS Foundation Trust
Portsmouth Hospitals NHS Trust
Henan Cancer Hospital
Fujian Cancer Hospital
Chinese Academy of Sciences
Papworth Hospital NHS Foundation Trust
Henan Cancer Hospital
Zagazig University
Tata Memorial Hospital
Tata Memorial Hospital
National Cancer Center, Korea
Fujian Cancer Hospital
Chinese Academy of Sciences
Department of Medical Services Ministry of Public Health of Thailand
Dr. Soetomo General Hospital
Taipei Veterans General Hospital, Taiwan
Instituto Nacional de Cancer, Brazil
University Hospital, Angers
National Institute of Cancerología
Sheba Medical Center
National Institute of Cancerología
Princess Margaret Hospital, Hong Kong
Tel-Aviv Sourasky Medical Center
University Hospital, Angers